SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004769
Filing Date
2022-03-30
Accepted
2022-03-30 16:47:57
Documents
80
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cycc-20211231x10k.htm   iXBRL 10-K 1927776
2 EX-4.10 cycc-20211231xex4d10.htm EX-4.10 159942
3 EX-23.1 cycc-20211231xex23d1.htm EX-23.1 2715
4 EX-31.1 cycc-20211231xex31d1.htm EX-31.1 12610
5 EX-31.2 cycc-20211231xex31d2.htm EX-31.2 12632
6 EX-32.1 cycc-20211231xex32d1.htm EX-32.1 6404
7 EX-32.2 cycc-20211231xex32d2.htm EX-32.2 6496
  Complete submission text file 0001558370-22-004769.txt   8019946

Data Files

Seq Description Document Type Size
8 EX-101.SCH cycc-20211231.xsd EX-101.SCH 54899
9 EX-101.CAL cycc-20211231_cal.xml EX-101.CAL 56298
10 EX-101.DEF cycc-20211231_def.xml EX-101.DEF 244309
11 EX-101.LAB cycc-20211231_lab.xml EX-101.LAB 450543
12 EX-101.PRE cycc-20211231_pre.xml EX-101.PRE 396126
74 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20211231x10k_htm.xml XML 1219618
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 22787175
SIC: 2834 Pharmaceutical Preparations